Negative Ultraselection of Patients With <i>RAS</i>/<i>BRAF</i> Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy - Concepedia

Concepedia

Publication | Open Access

Negative Ultraselection of Patients With <i>RAS</i>/<i>BRAF</i> Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy

DOI Full Paper Access

28

Citations

26

References

2022

Year

Giovanni Randon, Giulia Maddalena, Marco Maria Germani, Chiara Pircher, Paolo Manca, Francesca Bergamo, Mirella Giordano, Caterina Sposetti, Aldo Montagna, Guglielmo Vetere,

JCO Precision Oncology

Abstract

Negative ultraselection warrants further investigation with the aim of maximizing the benefit of EGFR blockade strategies in patients with <i>RAS</i> and <i>BRAF</i> wild-type, microsatellite stable mCRC.

References

	Year	Citations

Page 1